| http://www.w3.org/ns/prov#value | - Fueling growth are factors such as introduction of new products, enhanced ac...Launch of Targeted Agents and Increased Use of Maintenance Therapy Will Drive the Non-Small-Cell Lung Cancer Drug Market to Nearly Triple to Almost $10 Billion in 2018...ere is a place for this practice in the treatment of advanced disease. owing to sales of Eli Lilly's Alimta and Gemzar, Roche/Chugai's Avastin and OSI/
|
